ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function

Neuropharmacology. 2009 Jan;56(1):121-30. doi: 10.1016/j.neuropharm.2008.08.016. Epub 2008 Aug 22.

Abstract

Kainate receptors (KARs) are involved in both NMDA receptor-independent long-term potentiation (LTP) and synaptic facilitation at mossy fibre synapses in the CA3 region of the hippocampus. However, the identity of the KAR subtypes involved remains controversial. Here we used a highly potent and selective GluK1 (formerly GluR5) antagonist (ACET) to elucidate roles of GluK1-containing KARs in these synaptic processes. We confirmed that ACET is an extremely potent GluK1 antagonist, with a Kb value of 1.4+/-0.2 nM. In contrast, ACET was ineffective at GluK2 (formerly GluR6) receptors at all concentrations tested (up to 100 microM) and had no effect at GluK3 (formerly GluR7) when tested at 1 microM. The X-ray crystal structure of ACET bound to the ligand binding core of GluK1 was similar to the UBP310-GluK1 complex. In the CA1 region of hippocampal slices, ACET was effective at blocking the depression of both fEPSPs and monosynaptically evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist. In the CA3 region of the hippocampus, ACET blocked the induction of NMDA receptor-independent mossy fibre LTP. To directly investigate the role of pre-synaptic GluK1-containing KARs we combined patch-clamp electrophysiology and 2-photon microscopy to image Ca2+ dynamics in individual giant mossy fibre boutons. ACET consistently reduced short-term facilitation of pre-synaptic calcium transients induced by 5 action potentials evoked at 20-25Hz. Taken together our data provide further evidence for a physiological role of GluK1-containing KARs in synaptic facilitation and LTP induction at mossy fibre-CA3 synapses.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Alanine / analogs & derivatives
  • Alanine / chemistry
  • Alanine / pharmacology
  • Animals
  • Calcium / metabolism
  • Cell Line, Transformed
  • Crystallography, X-Ray / methods
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Excitatory Amino Acid Agonists / chemistry*
  • Excitatory Amino Acid Agonists / pharmacology*
  • Excitatory Amino Acid Antagonists / pharmacology
  • Female
  • Hippocampus / cytology
  • Humans
  • In Vitro Techniques
  • Models, Molecular
  • Mossy Fibers, Hippocampal / drug effects*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiology
  • Rats
  • Receptors, Kainic Acid / antagonists & inhibitors*
  • Receptors, Kainic Acid / genetics
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Transfection
  • Uracil / analogs & derivatives
  • Uracil / chemistry
  • Uracil / pharmacology

Substances

  • 1-(2-amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-ylmethyl)-5-methylpyrimidine-2,4-dione
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • Receptors, Kainic Acid
  • Uracil
  • Alanine
  • Calcium